Cargando…
FDA in the twenty-first century: the challenges of regulating drugs and new technologies
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033435/ http://dx.doi.org/10.1093/jlb/lsw004 |
| _version_ | 1782455144216002560 |
|---|---|
| author | Abbott, Ryan |
| author_facet | Abbott, Ryan |
| author_sort | Abbott, Ryan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5033435 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-50334352016-10-21 FDA in the twenty-first century: the challenges of regulating drugs and new technologies Abbott, Ryan J Law Biosci Corrigendum Oxford University Press 2016-02-15 /pmc/articles/PMC5033435/ http://dx.doi.org/10.1093/jlb/lsw004 Text en © The Author 2016. Published by Oxford University Press on behalf of Duke University School of Law, Harvard Law School, Oxford University Press, and Stanford Law School. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Corrigendum Abbott, Ryan FDA in the twenty-first century: the challenges of regulating drugs and new technologies |
| title | FDA in the twenty-first century: the challenges of regulating drugs and new technologies |
| title_full | FDA in the twenty-first century: the challenges of regulating drugs and new technologies |
| title_fullStr | FDA in the twenty-first century: the challenges of regulating drugs and new technologies |
| title_full_unstemmed | FDA in the twenty-first century: the challenges of regulating drugs and new technologies |
| title_short | FDA in the twenty-first century: the challenges of regulating drugs and new technologies |
| title_sort | fda in the twenty-first century: the challenges of regulating drugs and new technologies |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033435/ http://dx.doi.org/10.1093/jlb/lsw004 |
| work_keys_str_mv | AT abbottryan fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies |